Company / Return on Assets (ROA)
Insight Molecular Diagnostics Inc. Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-235.5%
FY2025
5-year range
-235.5% / -18.8%
FY2021-FY2025
Trend
-197.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 6 years, ranging from -235.5% in FY2025 to -18.8% in FY2021.
Based on SEC 10-K filings.
-235.5% in FY2025 with a 5-year CAGR of -195.1%.
Declined from -97.3% to -235.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -171.5pp
- 5-Year Change
- -195.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 197.4% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -235.5% | -197.4% |
| FY2024 | -79.2% | +18.6% |
| FY2023 | -97.3% | -52.0% |
| FY2022 | -64.0% | -241.4% |
| FY2021 | -18.8% | +53.6% |
| FY2020 | -40.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026